Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ThromboView in Deep Vein Thrombosis
NCT00123734Phase 2Completed
- Sponsor
- Agen Biomedical
- Start
- Mar 2005
- Countries
- 2
01
Overview
A Phase 2 trial of regorafenib + TAS-102-Agen Biomedical-deep vein thrombosis in deep vein thrombosis (DVT), sponsored by Agen Biomedical. Started Mar 2005; status: completed.
02
Drugs
regorafenib + TAS-102-Agen Biomedical-deep vein thrombosis
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT00123734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00123734.